Medicare patients who were at the highest risk of severe COVID-19 infections were less likely to get Paxlovid or other treatments, according to new research.
By Will Feuer Abbott Laboratories posted higher sales in the fourth quarter, despite continued soft demand for the company's Covid-19 testing equipment. The.
By Chris Wack Capricor Therapeutics shares were up 7% at $4.42 after the company said its proprietary StealthX exosome-based multivalent vaccine for the.